Back to top

ESCROW AGREEMENT

Trademark License Agreement

ESCROW AGREEMENT | Document Parties: IMARX THERAPEUTICS INC | Abbott Laboratories | LASALLE BANK NATIONAL ASSOCIATION You are currently viewing:
This Trademark License Agreement involves

IMARX THERAPEUTICS INC | Abbott Laboratories | LASALLE BANK NATIONAL ASSOCIATION

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: ESCROW AGREEMENT
Governing Law: Delaware     Date: 5/19/2006
Law Firm: Kirkland & Ellis LLP;DLA Piper Rudnick Gray Cary LLP    

ESCROW AGREEMENT, Parties: imarx therapeutics inc , abbott laboratories , lasalle bank national association
50 of the Top 250 law firms use our Products every day

<PAGE>

                                                                   Exhibit 10.15

                                ESCROW AGREEMENT

     THIS ESCROW AGREEMENT (the "Agreement") is made and entered into as of
April ___, 2006, by and among Abbott Laboratories, a corporation organized and
existing under the laws of the State of Illinois and having a principal place of
business at 100 Abbott Park Road, Abbott Park, Illinois 60064 ("Abbott") and
ImaRx Therapeutics, Inc., a corporation organized and existing under the laws of
Delaware and having a principal place of business at 1635 East 18th Street,
Tucson, Arizona 85719 ("ImaRx"), and LaSalle Bank National Association, a
national banking association duly organized and existing under the laws of the
United States of America, with its principal office in Chicago, Illinois (the
"Escrow Agent").

     WHEREAS, ImaRx and Abbott are parties to an Asset Purchase Agreement (the
"Purchase Agreement") dated as of April 10, 2006.

     WHEREAS, ImaRx is the maker of a Secured Promissory Note (the "Note"),
dated as of even date herewith in favor of Abbott in the principal amount of
$15,000,000.

     WHEREAS, pursuant to the terms of the Security Agreement (the "Security
Agreement") by and between Abbott and ImaRx, the Obligations (as defined in the
Note) of ImaRx are secured by the Collateral (as defined in the Security
Agreement).

     WHEREAS, among other things, the Collateral includes any and all proceeds
(the "Proceeds") from the sale or transfer of the Inventory (as defined in the
Purchase Agreement), which such Proceeds are to be held in escrow, pursuant to
the terms of the Security Agreement.

     NOW, THEREFORE, in consideration of the mutual promises contained herein
and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereto agree as follows:

                                    ARTICLE I
                             ESTABLISHMENT OF ESCROW

1.1 From and after the execution of this Agreement, the following will occur,
all of which shall be acknowledged by Abbott, ImaRx, and the Escrow Agent:

     (a) Within five Business Days, ImaRx will deposit with the Escrow Agent 50%
of the proceeds of any sales of Inventory in the ordinary course of business,
consistent with past practice after ImaRx has received proceeds from such sales
equal to Five Million U.S. dollars. Such deposits, together with any investment
earnings thereon, shall hereinafter collectively be referred to as the "Escrow
Fund." ImaRx shall make the deposits referenced in this Section 1.1(a) until the
earlier of (A) the Note being repaid in full or (B) ImaRx having deposited
Fifteen Million U.S. dollars with the Escrow Agent.

     (b) Abbott and ImaRx hereby appoint the Escrow Agent, and the Escrow Agent
hereby agrees to serve, as the escrow agent and depositary subject to the terms
and conditions set forth herein. The Escrow Agent shall receive the Proceeds and
agrees to hold the Escrow Fund in a separate and distinct account (the "Escrow
Account") which, subject to the terms and




<PAGE>

conditions of this Agreement, will be available for disbursement to ImaRx or
Abbott at the Escrow Agent's office in Chicago, Illinois. The Escrow Agent shall
not distribute or release any of the Escrow Fund except in accordance with the
express terms and conditions of this Agreement.

                                   ARTICLE II
                            INVESTMENT OF ESCROW FUND

2.1 The Escrow Fund shall be invested as soon as reasonably practicable,
including income earned on said investment, in the Federated Treasury
Obligations Fund (Trust Shares).

2.2 The Escrow Agent shall not be responsible to Abbott or ImaRx or any other
person or entity for any loss or liability arising in respect of any directed
investment in Section 2.1 except to the extent that such loss or liability arose
from the Escrow Agent's gross negligence or willful misconduct.

                                   ARTICLE III
                      DISBURSEMENTS FROM THE ESCROW ACCOUNT

3.1 The Escrow Agent shall only disburse amounts held in the Escrow Account as
follows:

     (a) If on or before December 31, 2007, Abbott and ImaRx each execute and
deliver a written notice of termination (the "Repayment Notice") to the Escrow
Agent notifying the Escrow Agent of ImaRx' indefeasible payment in full of
ImaRx' Obligations under the Note, then within 2 Business Days of the date that
the Escrow Agent receives the Repayment Notice, the Escrow Agent shall deliver
the Escrow Fund to ImaRx in accordance with the instructions for payment
provided in the Repayment Notice.

     (b) If the Escrow Agent does not receive the Repayment Notice on or before
December 31, 2007, then on December 31, 2007, the Escrow Agent shall deliver the
Escrow Fund to Abbott via wire transfer of immediately available funds, in
accordance with Abbott's written instructions less the amount of any written
claim against the Escrow Fund delivered to Escrow Agent by Abbott and ImaRx
prior to such date (a "Claim), in which event the Escrow Agent shall deliver an
amount equal to the Escrow Fund less the amount of the Claim to Abbott via wire
transfer of immediately available funds, in accordance with Abbott's written
instructions, and shall hold the balance of the Escrow Fund pending resolution
of the Claim pursuant to Section 5.3.

     (c) At any time prior to December 31, 2007, ImaRx may, by delivery of
written notice to the Escrow Agent and Abbott, instruct the Escrow Agent to pay
such amounts from the Escrow Account to Abbott as ImaRx may instruct.

     (d) On the 15th day of each calendar month following the date hereof, the
Escrow Agent shall deliver to Abbott and ImaRx a statement detailing the amounts
deposited into the Escrow Account as of such date.


                                         2

<PAGE>

                                   ARTICLE IV
                             COMPENSATION; EXPENSES

4.1 In consideration for its services as Escrow Agent, the Escrow Agent shall be
entitled to receive the compensation set forth in Exhibit A hereto, as well as
the reimbursement of all reasonable out-of-pocket costs and expenses actually
incurred by the Escrow Agent in the performance of its duties hereunder. Abbott
and ImaRx shall share equally such compensation and expenses.

4.2 To the extent any amount due to the Escrow Agent pursuant to Section 4.1 is
not paid, the Escrow Agent shall notify all parties hereto and if such amount is
not paid within five (5) Business Days of such notice, then the Escrow Agent may
deduct the same from the Escrow Account. In the event that Escrow Agent has
offset such fees and expenses from the Escrow Fund, the party or parties failing
to pay the same directly to Escrow Agent shall promptly reimburse the Escrow
Fund for the same.

                                     ARTICLE V
                         EXCULPATION AND INDEMNIFICATION

5.1 The obligations and duties of the Escrow Agent are confined to those
specifically set forth in this Agreement. In the event that any of the terms and
provisions of any other agreement between any of the parties hereto conflict or
are inconsistent with any of the terms and provisions of this Agreement, the
terms and provisions of this Agreement shall govern and control in all respects.
The Escrow Agent shall not be subject to, nor be under any obligation to
ascertain or construe the terms and conditions of any other instrument, whether
or not now or hereafter deposited with or delivered to the Escrow Agent or
referred to in this Agreement, nor shall the Escrow Agent be obligated to
inquire as to the form, execution, sufficiency, or validity of any such
instrument nor to inquire as to the identity, authority, or rights of the person
or persons executing or delivering same.

5.2 The Escrow Agent shall not be personally liable for any act that it may do
or omit to do hereunder in good faith and in the exercise of its own best
judgment. Any act done or omitted to be done by the Escrow Agent pursuant to the
advice of its attorneys shall be deemed conclusively to have been performed or
omitted in good faith by the Escrow Agent.

5.3 In the event the Escrow Agent is notified of


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more